About This Publication:

  • Print This Page
  • Text a Friend
  • Subscribe to an RSS Feed

Sample Content 

LOGIN


Sign up to stay informed--receive email notifications for this journal

ASSAY and Drug Development Technologies

Editor-in-Chief: Jim Inglese, PhD

ISSN: 1540-658X • 10 Issues Annually • Online ISSN: 1557-8127

Current Volume: 11

Latest Impact Factor* is 1.896

*2012 Journal Citation Reports® published by Thomson Reuters, 2013

Open Access Options for this Peer-Reviewed Journal

 

Benefits of Liebert Open Access:

Authors and research funders who chose to have their original research articles posted free online with immediate, unrestricted Open Access (OA) pay a one-time $3,200 article processing charge (APC). This article OA investment ensures the widest visibility, discoverability, and application of the funded research. Institutions and funders may support OA for their researchers by participating in the Liebert Author Advocacy Program (LAAP) which entitles authors to a 25% reduction of APC charges on articles published in Liebert journals.

OA Author benefits include:

  • Fast track ONLINE publication and deposit to internationally recognized repositories (such as PubMedCentral*)
  • Universally and freely available article access via the Internet
  • Article recognition on TOC with OA icon and proper attribution of authorship, source, and full citation details
  • Targeted email marketing announcement highlighting OA article
  • Compliance with OA funding mandates with no embargo period
  • Increased visibility - readership, citations, downloads

LAAP Author benefits:

Authors whose institutions are members of the LAAP program receive all OA benefits above at a 25% reduction of APC fee, as well as enhanced marketing and author networking services through the AuthorCite program. AuthorCite charter membership is complimentary for LAAP participants, and provides extended author services including:

  • Personalized author profile and microsite
  • Manuscript submission and article tracking service
  • Article citation tracking tool and metrics
  • Author CV and contact management tool
  • OpenLink™ article research sharing

Contact openaccess@liebertpub.com for questions on article Open Access options.
Contact laap@liebertpub.com to learn more about LAAP participation benefits.
Contact authorcite@liebertpub.com to learn more about AuthorCite™ services.

The Liebert Open Access program supports global OA research mandates from leading funding bodies including the NIH, Wellcome Trust and HHMI among others.

 

*Please note that PubMedCentral, not the Publisher, has sole control over when the paper is made live on PMC.

The views, opinions, findings, conclusions and recommendations set forth in any Journal article are solely those of the authors of those articles and do not necessarily reflect the views, policy or position of the Journal, its Publisher, its editorial staff or any affiliated Societies and should not be attributed to any of them.

Recommended Publications

You may be interested in the following publications:

    OMICS: A Journal of Integrative Biology

    OMICS: A Journal of Integrative Biology

    The only peer-reviewed interdisciplinary publication covering all "OMICS"-related science, such as integrative biology and medicine. The Journal also reports on all methods and resources underpinning integrative research.

    Journal of Computational Biology

    Journal of Computational Biology

    The leading peer-reviewed journal in the analysis, management, and visualization of cellular information at the molecular level, offering articles on novel, cutting-edge methods in computational biology and bioinformatics.

    Zebrafish

    Zebrafish

    Solely focused on disseminating the latest cutting-edge advances in the zebrafish as a model organism for the study of vertebrate development, with attention to other aquarium species including medaka, Fugu, and Xiphophorus.

    Antioxidants & Redox Signaling

    Antioxidants & Redox Signaling

    The leading resource for the latest research and information on antioxidants and redox biology. The Journal explores key aspects of the important and expanding world of redox-based therapeutics.

    AIDS Research and Human Retroviruses

    AIDS Research and Human Retroviruses

    The leading journal in the field for over 25 years, providing the latest developments and research advances in HIV/AIDS and other retroviruses leading to improvements in translational medicine for optimal treatment outcomes.

    Genetic Engineering & Biotechnology News

    Genetic Engineering & Biotechnology News

Browse All Publications »